Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
CD Protein Inhibitors
>>
Phase 1
«
1
2
3
4
5
6
7
8
9
10
11
12
13
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
yttrium Y 90 anti-CD19 Ab
(BU 12) / National Cancer Institute
zeushield cytotoxic T lymphocyte therapy
/ Hunan Yongren Medical Innovation, Hunan Zhaotai Yongren
«
1
2
3
4
5
6
7
8
9
10
11
12
13
